These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31370810)

  • 21. Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal.
    Brennan T; Hidle A; Doshi RH; An Q; Loharikar A; Casey R; Badiane O; Ndiaye A; Diallo A; Loko Roka J; Mejia N; Abimbola T
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A77-A84. PubMed ID: 34955325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planning for human papillomavirus (HPV) vaccination in sub-Saharan Africa: a modeling-based approach.
    Tracy JK; Schluterman NH; Greene C; Sow SO; Gaff HD
    Vaccine; 2014 May; 32(26):3316-22. PubMed ID: 24731734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
    Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
    PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls.
    Bardají A; Mindu C; Augusto OJ; Casellas A; Cambaco O; Simbine E; Matsinhe G; Macete E; Menéndez C; Sevene E; Munguambe K
    Papillomavirus Res; 2018 Jun; 5():156-162. PubMed ID: 29665430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive approach to costing cervical cancer prevention and control: a case study in the United Republic of Tanzania using the Cervical Cancer Prevention and Control Costing (C4P) tool.
    Levin A; Yuma S; Swai E; Morgan W; Gauvreau CL; Broutet N; Yeung KHT; Hutubessy R
    BMC Med; 2022 Nov; 20(1):384. PubMed ID: 36316680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.
    Ngabo F; Levin A; Wang SA; Gatera M; Rugambwa C; Kayonga C; Donnen P; Lepage P; Hutubessy R
    Vaccine; 2015 Dec; 33(51):7357-7363. PubMed ID: 26519548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.
    Levin CE; Van Minh H; Odaga J; Rout SS; Ngoc DN; Menezes L; Araujo MA; LaMontagne DS
    Bull World Health Organ; 2013 Aug; 91(8):585-92. PubMed ID: 23940406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
    Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
    Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Prinja S; Bahuguna P; Faujdar DS; Jyani G; Srinivasan R; Ghoshal S; Suri V; Singh MP; Kumar R
    Cancer; 2017 Sep; 123(17):3253-3260. PubMed ID: 28472550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme.
    Muhamad NA; Buang SN; Jaafar S; Jais R; Tan PS; Mustapha N; Lodz NA; Aris T; Sulaiman LH; Murad S
    BMC Public Health; 2018 Dec; 18(1):1402. PubMed ID: 30577816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach.
    Vanni T; Luz PM; Foss A; Mesa-Frias M; Legood R
    Vaccine; 2012 Jul; 30(32):4866-71. PubMed ID: 22652405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia.
    Aljunid S; Orhun NM; Nur AM; Noor MRM; Wan Puteh SE
    BMC Public Health; 2016 Jan; 16():71. PubMed ID: 26803814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Wolff E; Elfström KM; Haugen Cange H; Larsson S; Englund H; Sparén P; Roth A
    Vaccine; 2018 Aug; 36(34):5160-5165. PubMed ID: 30017146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting.
    Sharma M; Sy S; Kim JJ
    BJOG; 2016 May; 123(6):917-26. PubMed ID: 26176301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR).
    Soi C; Gimbel S; Chilundo B; Muchanga V; Matsinhe L; Sherr K
    Implement Sci; 2018 Dec; 13(1):151. PubMed ID: 30545391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.